Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Quick Stats
Mar 30, 202658.5
AI Score
HOLD0.06
Volume Ratio
May 07, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
IDXX Stock Summary
Last updated
IDXX is currently trading at $563.76, positioned below its 200-day moving average of $636.62, suggesting bearish momentum. The stock has a 52-week range of $356.14 to $769.98.
Technical Analysis: The 50-day moving average stands at $630.01, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates IDXX at 58.5/100 with a HOLD recommendation.
IDXX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
IDXX Price vs Max Options Open Interest
IDXX Max Change In Options Open Interest
IDXX Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IDXX Daily Out of Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IDXX Daily In the Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IDXX Most Active Options by Volume(near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Idexx Laboratories Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
IDXX Moving Averages Analysis
IDXX (Idexx Laboratories Inc) Simple Moving Averages
Moving Averages are last updated Mar 30, 2026
| Days | MA |
|---|---|
| 10 | 574.1 |
| 20 | 589.69 |
| 30 | 606.84 |
| 50 | 630.01 |
| 100 | 668.72 |
| 200 | 636.62 |
IDXX Fundamental Analysis
| P/E (Forward) | 40.1606 |
| P/E (Trailing) | 43.863 |
| Market Cap ($) | 45.8 billion |
| Earnings/Share ($) | 13.07 |
| Net Proft Margin (%) | 0.2462 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 14.5119 |
| EPS Estimate Next Year ($) | 16.3916 |
| WallStreet Target Price ($) | 750.2308 |
| Most Recent Quarter |